惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

C
Cisco Blogs
爱范儿
爱范儿
有赞技术团队
有赞技术团队
博客园 - 【当耐特】
Jina AI
Jina AI
Project Zero
Project Zero
宝玉的分享
宝玉的分享
Martin Fowler
Martin Fowler
WordPress大学
WordPress大学
Simon Willison's Weblog
Simon Willison's Weblog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
T
Tenable Blog
F
Fortinet All Blogs
大猫的无限游戏
大猫的无限游戏
Last Week in AI
Last Week in AI
月光博客
月光博客
雷峰网
雷峰网
G
Google Developers Blog
V
V2EX
T
Tor Project blog
罗磊的独立博客
Schneier on Security
Schneier on Security
Know Your Adversary
Know Your Adversary
W
WeLiveSecurity
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
P
Privacy International News Feed
S
Securelist
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
P
Proofpoint News Feed
Blog — PlanetScale
Blog — PlanetScale
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
小众软件
小众软件
Scott Helme
Scott Helme
I
Intezer
T
Threat Research - Cisco Blogs
The GitHub Blog
The GitHub Blog
N
Netflix TechBlog - Medium
C
CERT Recently Published Vulnerability Notes
Security Archives - TechRepublic
Security Archives - TechRepublic
酷 壳 – CoolShell
酷 壳 – CoolShell
L
LINUX DO - 最新话题
N
News | PayPal Newsroom
L
Lohrmann on Cybersecurity
T
Troy Hunt's Blog
Google DeepMind News
Google DeepMind News
P
Proofpoint News Feed
人人都是产品经理
人人都是产品经理
Latest news
Latest news
AWS News Blog
AWS News Blog
Apple Machine Learning Research
Apple Machine Learning Research

Stocks Fundamentals Analysis India | The HinduBusinessLine

Who Am I? June 21, 2026 Shyam Metalics: What Should Investors Do? Turtlemint Fintech Solutions IPO: Should You Subscribe? Covers for Cancer Treatment Wonderla, V-Guard, Havells, Voltas, UBL, Blue Star, Emami: Hot Summer, Cold Stocks? Why Buy This Luxury Hotel on Dips Who Am I? June 14, 2026 Polycab India: What Should Investors Do? Kotak Mahindra Bank: Good time to relook? Who Am I? June 7, 2026 Cipla: Tonic For The Patient Investor JSW Steel: Will plans to double capacity boost stock price? Emami stock: Why this FMCG stock is a buy near its 52-week low Who Am I? May 31, 2026 Medanta: What Should Investors Do? Should investors buy HDFC Bank now? SpaceX IPO and the Big Bang Bubble Who Am I? May 24, 2026 Simply Put: Interest Coverage Ratio Who Am I? May 17, 2026 What They Say on Their India Plans SRF: On The Road to Recovery Godrej Agrovet Accumulate Call Palm Oil Animal Nutrition Outlook The Ramco Cements: What Should Investors Do? Nifty 50, Nifty 500: PE multiples can be the same number yet poles apart SAMHI Hotels stock call: Accumulate on dips What They Say on Their India Plans Who Am I? May 10, 2026 Who Am I? May 3, 2026 What They Say on Their India Plans Wait for the fog to clear first! Steel Authority of India: With SAIL shares at a 15-year high, what should investors do? Sun Pharma-Organon deal: Outlook is mixed Banking on valuation comfort Jyothy Labs: Why the stock is a buy after 30 pc drop in last 1 year What They Say on Their India Plans Who Am I? April 26, 2026 HDFC Bank: Key takeaways for investors from Q4 results Narayana Health: Heart At The Right Place Who Am I? April 19, 2026 Citius TransNet InvIT IPO: Should you apply? What the numbers say The sector call illusion Caplin Point: Consolidating before the next leg of growth Who Am I? April 12, 2026 Banking on a transformation Who Am I? April 5, 2026 Zydus Lifesciences: Bridging the gap What should investors do about Bosch shares New India Assurance stock call: Should investors accumulate on dips? Will this engineering behemoth stock fix the dented investor confidence? Who Am I? March 29, 2026 Equities, Bonds, Commodities, Currencies et al: How They Fare Three Weeks into the US-Iran War Navin Fluorine: What Should You Do? Who Am I? March 22, 2026 HDFC Bank’s Part-time Chairman resigns: What investors need to know CMPDI IPO Review: Subscribe to Central Mine Planning & Design Institute Issue? Who Am I? March 15, 2026 Ambuja Cements: What Should You Do? IHCL stock: Accumulate on dips after correction Raajmarg Infra Investment Trust IPO: Should you invest? AMC stocks defy markets, enjoy outperformance and premium valuations United Breweries Hold Call: Margin Gains Help, But Valuation Remains Rich PG Electroplast stock: Hot Summer, Hotter Sales Who Am I? March 8, 2026 Should you subscribe to Sedemac Mechatronics IPO? Who Am I? March 1, 2026 ITC Hotels: Accumulate on dips as valuation cools and asset-light growth gathers pace Lumax Industries: Should You Book Profit After The Small-Cap’s Stellar Run? What They Say on Their India Plans DLF: A Premium Residential and Commercial Spaces Play Clean Max IPO: Should You Subscribe? Who Am I? Feb 22, 2026 Tata Motors: What investors need to know about the demerged commercial vehicle business Who Am I? Feb 15, 2026 Sun Pharma: What should investors do? What the merger of PFC and REC means for investors India Inc delivers well in Q3 FY26 NBCC: A Solid Construction Play on Government Capex Fractal Analytics IPO review: Valuation looks demanding amid AI disruption Who Am I? Feb 8, 2026 How market fares around Budgets Dr. Reddy and Cipla: Growth in the post-Lenalidomide era for pharma stocks Who Am I? Feb 1, 2026 Who Am I? Jan 25, 2026 Should You Consider Buying Bank of Maharashtra’s Stock? What investors need to glean from HDFC Bank’s Q3 results Neuland Laboratories: What Should Investors Do? Who Am I? Jan 18, 2026 Shadowfax IPO Review: Fast Growth, Thin Margins — Subscribe or Wait? Amagi Media Labs IPO: Are valuations outpacing profits for this SaaS company? Nexus Select Trust: Yielding More on Urban Consumption Who Am I? Jan 11, 2026 BCCL IPO: Cheap on paper, costly in a downcycle; why Coal India may be the smarter pick Mankind Pharma: Finding synergies amidst transformation What Should Investors Do About The PNB Housing Finance Stock? Who Am I? Jan 4, 2026 Chalet Hotels: Buy, Sell or Hold? Shree Cement: What Should Investors Do? Who Am I? Dec 28, 2025 ICICI Prudential Life: Is The Least Expensive Life Insurer A Good Bet Now?
Decoding Life Insurers
By Kumar Shankar Roy · 2025-12-20 · via Stocks Fundamentals Analysis India | The HinduBusinessLine

Life insurers are best read through a small dashboard of terms. Here’s an explanation of the key terms and what each tells an investor.

Embedded Value (EV): This is the insurer’s net worth plus the present value of profits expected from policies already on the books. EV is a better “core value” anchor than earnings for life insurers; steady EV growth usually signals a compounding franchise.

Embedded Value Operating Profit (EVOP): EVOP is the change in embedded value from the start to the end of the period, after removing market or economic variances, changes in actuarial assumptions or models, and capital movements such as dividends, buybacks or fresh capital injections. Track EVOP alongside EV growth to judge whether value creation is coming from core execution rather than market tailwinds or assumption resets.

Price-to-Embedded Value (P/EV): This is measured by stock price divided by EV. It is the most-used valuation multiple for life insurers. Compared to peers, a low P/EV can mean value, or a deserved discount.

Linked products (market-linked): In these products (ULIPs), benefits depend on market performance. Linked-heavy mix can boost volumes in bull markets, but growth and margins can become more cycle-sensitive.

Non-linked products (non-market-linked): In these products, benefits are not tied to markets; outcomes come from guarantees, declared bonuses or fixed benefit structures.

This bucket includes three sub-buckets:

Non-linked savings: Under it are par and non-par plans. In par (participating), policyholders have a share in surplus via bonuses as declared by the insurer. Common products include traditional participating endowment plans, moneyback plans (often sold as par) and participating savings plans. They can support stability and franchise, but profitability depends on bonus discipline and investment returns. In non-par, there is no surplus sharing; guarantees/pricing are explicit upfront in these plans that include guaranteed return plans, non-par endowments and fixed-benefit savings plans. They can be margin-accretive if priced right, but sensitive to interest rates and ALM (asset-liability management).

Protection (usually non-linked): These plans are pure risk cover (term-style economics), not savings-led. Common product names include term plans, return of premium term plans and group term. They carry higher margins and improve “quality” of growth, but require disciplined underwriting and claims management.

Annuity / pension (usually non-linked): These are long-duration income products with fixed/declared payouts. They are stable if ALM is strong; watch investment yield, duration matching and solvency.

Group business: These are group insurance/pension-style business sourced from institutions. Group can add scale, but may be price-competitive and lower-margin; it can also be more sensitive to large-ticket renewals.

APE (Annual Premium Equivalent): It is calculated as the full annualised value of regular (recurring) premiums written during the period, plus 10 per cent of single premiums written during the period. APE is the go-to “growth” line for life insurers; track it with product mix, so you don’t confuse volume with quality.

NBP (New Business Premium): This is total premium from policies sold during the period (single premium + first-year premiums). NBP can look strong even when quality is weak; always pair it with APE, mix and margins.

VNB (Value of New Business): This is present value of profits expected from policies sold in the period. VNB is the best single metric for profitable growth; rising VNB with stable assumptions is a strong signal.

VNB margin: This is VNB as a percentage of APE (or new business premium, depending on disclosure). This margin tells you if growth is being “bought” via pricing cuts or higher commissions; sustainable re-rating usually needs stable-to-rising VNB margin.

Persistency: This is the share of policies still in force after 13/25/37/49/61 months. Persistency is a direct driver of EV and VNB quality; weak persistency often explains why a stock stays at a discount. Note that the 61st month is the ultimate test of stickiness.

Solvency ratio: It tells you how many times the insurer’s available capital buffer covers the minimum required buffer. Strong solvency gives room to grow and absorb shocks; low solvency constrains growth and increases downside in stress scenarios.

Published on December 20, 2025